The Section of Pulmonary, Critical Care, and Sleep Medicine has strong nationally recognized research programs in lung diseases and critical care medicine.

The faculty performs a wide spectrum of research activities including investigations into the molecular mechanisms of lung diseases and translational research studies, as well as clinical trials. Clinical trials include Phase I, II and III studies, and are conducted in various hospitals and clinics in the Texas Medical Center. The research in the section is supported by $4.8 million from federal and private research grants.

Areas of active research in the section include investigation into the pathogenesis and potential novel therapeutic strategies for diseases such as asthma, chronic obstructive lung diseases, interstitial lung diseases, pulmonary hypertension, pulmonary fibrosis, lymphangioleiomyomatosis, transition medicine, lung transplant, lung cancer, and cystic fibrosis.

Clinical Trials

The section also conducts clinical trials or research protocols – to test whether a new drug, new prevention, diagnostic strategy, or new screening test is safe and effective in people. Participation is always voluntary. The investigators in our section conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions. To find out more, visit our clinical trial site or call a volunteer number below.

  • Asthma/COPD - For more information, please call the COPD Hotline (713) 798-COPD.
  • Pulmonary Hypertension - For current recruiting studies, please call (713) 798-2400.
  • Pulmonary Fibrosis - For current recruiting studies, please call (713) 798-2400.

Asthma Clinical Research Center

The section is also part of a nationwide clinical network of Asthma Clinical Research Centers sponsored by the American Lung Association. For more information, see Asthma Clinical Research Center at Baylor College of Medicine.